Indeed, using the TRPM7 inhibitor NS8593 suppressed TRPM7 expression and cell proliferation both in tubular epithelial cells and interstitial cells, prevented upregulation of Smad2/Smad3 signaling, and attenuated renal atrophy and fibrosis. This evidence concerns the gene SMAD3 and Renal atrophy.